Abcam Files And Mails Scheme Circular Seeking Approval Of Acquisition Of Abcam By Danaher For $24.00 Per Share
Portfolio Pulse from Benzinga Newsdesk
Abcam plc (NASDAQ:ABCM) has filed and mailed a scheme circular seeking approval for its acquisition by Danaher Corporation (NYSE:DHR) for $24.00 per share. The transaction represents a 39% premium to Abcam's undisturbed closing share price on May 16, 2023. The acquisition is the result of a competitive sale process, with Danaher's offer being the highest received. Post-acquisition, Abcam will continue as a standalone operating company and brand within Danaher's Life Sciences segment.
October 05, 2023 | 12:12 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Danaher is acquiring Abcam at a premium, which could lead to a short-term decrease in its stock price due to the cost of the acquisition.
The acquisition price represents a significant premium, which could lead to a short-term decrease in Danaher's stock price as investors react to the cost of the acquisition.
CONFIDENCE 90
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Abcam is being acquired by Danaher at a 39% premium to its undisturbed closing share price. This could lead to a short-term increase in the stock price.
The acquisition price represents a significant premium to Abcam's recent closing price, which could lead to a short-term increase in the stock price as investors react to the news.
CONFIDENCE 90
IMPORTANCE 100
RELEVANCE 100